Cellid, Co., Ltd. (KOSDAQ:299660)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2015
E-commerce	3.81B
New Drug Development	358.05M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2015
South Korea	4.17B

Data Source: Finnhub Last updated: Dec 31, 2024

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 7, 2026

Data Sources Report a data error